top of page
Search

Oticon Medical AB v. Cochlear Limited (P.T.A.B. Oct. 16, 2019)

The Patent Trial and Appeal Board designated this decision to institute an inter partes review as precedential.


In this case, the Board declined to exercise discretion to deny institution under 35 U.S.C. 325(d) because there was "new, noncumulative prior art in asserted in the Petition."


The Board also declined to exercise discretion to deny institution under 35 U.S.C. 314(a) because "[the] Patent Owner seems to acknowledge that the Board proceeding would not be directly duplicative of the District Court consideration of validity" and because there is no trial date set in the district court.


Read the case here.


Recent Posts

See All

U.S. Supreme Court opinion of Amgen Inc. v. Sanofi

Post by Paul Serbinowski What must the specification disclose to enable broad functional claim language? A week ago in Amgen Inc. v. Sanofi, the U.S. Supreme Court considered what the specification mu

Commenti


I commenti sono stati disattivati.
bottom of page